A Phase II Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients
Phase of Trial: Phase II
Latest Information Update: 21 Jan 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Oxaliplatin
- Indications Gastric cancer
- Focus Pharmacogenomic; Proof of concept; Therapeutic Use
- 21 Jan 2017 Results (n=85) presented at the 2017 Gastrointestinal Cancers Symposium.
- 24 May 2011 Actual initiation date (Jul 2010) added as reported by ClinicalTrials.gov.
- 24 May 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.